GTP-binding-defective forms of tissue transglutaminase trigger cell death

Biochemistry

Volumn 46, Issue 51, 2007, Pages 14819-14829

  Datta, Sunando ^a   Antonyak, Marc A ^a   Cerione, Richard A ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CELL DEATH; CROSSLINKING; DISEASES; GENE EXPRESSION;

APOPTOTIC ACTIVITIES; GTP BINDING DEFECTIVE FORMS; HYDROLYTIC ACTIVITIES;

ENZYMES;

GUANOSINE TRIPHOSPHATE; MUTANT PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ALZHEIMER DISEASE; AMIDATION; ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING AFFINITY; CATALYSIS; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; HYDROLYSIS; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BINDING SITES; CELL DEATH; CELL LINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GTP-BINDING PROTEINS; GUANOSINE TRIPHOSPHATE; HUMANS; HYDROLYSIS; MICE; MODELS, MOLECULAR; MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TRANSGLUTAMINASES;

EID: 37349100874     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi701422h     Document Type: Article

References (59)

1. Folk, J. E. (1980) Transglutaminases, Annu. Rev. Biochem. 49, 517-531.
2. Griffin, M., Casadio, R., and Bergamini, C. M. (2002) Transglutaminases: nature's biological glues, Biochem. J. 368, 377-396.
3. Lorand, L., and Graham, R. M. (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions, Nat. Rev. Mol. Cell Biol. 4, 140-156.
4. Fesus, L., and Szondy, Z. (2005) Transglutaminase 2 in the balance of cell death and survival, FEBS Lett. 579, 3297-3302.
5. Monsonego, A., Shani, Y., Friedmann, I., Paas, Y., Eizenberg, O., and Schwartz, M. (1997) Expression of GTP-dependent and GTP-independent tissue-type transglutaminase in cytokine-treated rat brain astrocytes, J. Biol. Chem. 272, 3724-3732.
6. Lesort, M., Chun, W., Johnson, G. V., and Ferrante, R. J. (1999) Tissue transglutaminase is increased in Huntington's disease brain, J. Neurochem. 73, 2018-2027.
7. Karpuj, M. V., Garren, H., Slunt, H., Price, D. L., Gusella, J., Becher, M. W., and Steinman, L. (1999) Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei, Proc. Natl. Acad. Sci. U.S.A. 96, 7388-7393.
8. Antonyak, M. A., Singh, U. S., Lee, D. A., Boehm, J. E., Combs, C., Zgola, M. M., Page, R. L., and Cerione, R. A. (2001) Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis, J. Biol. Chem. 276, 33582-33587.
9. Tucholski, J., Lesort, M., and Johnson, G. V. (2001) Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells, Neuroscience 102, 481-491.
10. Tucholski, J., and Johnson, G. V. (2002) Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner, J. Neurochem. 81, 780-791.
11. Antonyak, M. A., Miller, A. M., Jansen, J. M., Boehm, J. E., Balkman, C. E., Wakshlag, J. J., Page, R. L., and Cerione, R. A. (2004) Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells, J. Biol. Chem. 279, 41461-41467.
12. Lesort, M., Tucholski, J., Miller, M. L., and Johnson, G. V. (2000) Tissue transglutaminase: a possible role in neurodegenerative diseases. Prog. Neurobiol. 61, 439-463.
13. Olivero, S., Amendola, A., Rodolfo, C., Spinedi, A., and Piacentini, M. (1999) Inhibition of "tissue" transglutaminase increases cell survival by preventing apoptosis, J. Biol. Chem. 274, 34123-34128.
14. Piacentini, M., Martinet, N., Beninati, S., and Folk, J. E. (1988) Free and protein-conjugated polyamines in mouse epidermal cells. Effect of high calcium and retinoic acid, J. Biol. Chem. 263, 3790-3794.
15. Piacentini, M., Fesus, L., Farrace, M. G., Ghibelli, L., Piredda, L., and Melino, G. (1991) The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis), Eur. J. Cell Biol. 54, 246-254.
16. Johnson, G. V., Cox, T. M., Lockhart, J. P., Zinnerman, M. D., Miller, M. L., and Powers, R. E. (1997) Transglutaminase activity is increased in Alzheimer's disease brain, Brain Res. 751, 323-329.
17. Kim, S. Y., Grant, P., Lee, J. H., Pant, H. C., and Steinen, P. M. (1999) Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease, J. Biol. Chem. 274, 30715-30721.
18. Junn, E., Ronchetti, R. D., Quezado, M. M., Kim, S. Y., and Mouradian, M. M. (2003) Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies, Proc. Natl. Acad. Sci. U.S.A. 100, 2047-2052.
19. Kahlem, P., Green, H., and Djian, P. (1998) Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine, Mol. Cell. 1, 595-601.
20. Mastroberardino, P. G., Iannicola, C., Nardacci, R., Bernassola, F., De, Laurenzi, V., Melino, G., Moreno, S., Pavone, F., Oliverio, S., Fesus, L., and Piacentini, M. (2002) 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease, Cell Death Differ. 9, 873-880.
21. Dedeoglu, A., Kubilus, J. K., Jeitner, T. M., Matson, S. A., Bogdanov, M., Kowall, N. W., Matson, W. R., Cooper, A. J., Ratan, R. R., Beal, M. F., Hersch, S. M., and Ferrante, R. J. (2002) Therapeutic effects of cystamine in a murine model of Huntington's disease, J. Neurosci. 22, 8942-8950.
22. Karpuj, M. V., Becher, M. W., Springer, J. E., Chabas, D., Youssef, S., Pedotti, R., Mitchell, D., and Steinman, L. (2002) Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine, Nat. Med. 8, 143-149.
23. Boehm, J. E., Singh, U., Combs, C., Antonyak, M. A., and Cerione, R. A. (2002) Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb, J. Biol. Chem. 277, 20127-20130.
24. Herman, J. F., Mangala, L. S., and Mehta, K. (2006) Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells, Oncogene 25, 3049-3058.
25. Zhang, R., Tremblay, T. L., McDermid, A., Thibault, P., and Stanimirovic, D. (2003) Identification of differentially expressed proteins in human glioblastoma cell lines and tumors, Glia. 42, 194-208.
26. Yuan, L., Choi, K., Khosla, C., Zheng, X., Higashikubo, R., Chicoine, M. R., and Rich, K. M. (2005) Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas, Mol. Cancer Ther. 4, 1293-1302.
27. Datta, S., Antonyak, M. A., and Cerione, R. A. (2006) Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis, Biochemistry 45, 13163-13174.
28. Antonyak, M. A., Jansen, J. M., Miller, A. M., Ly, T. K., Endo, M., and Cerione, R. A. (2006) Two isoforms of tissue transglutaminase mediate opposing cellular fates, Proc. Natl. Acad. Sci. U.S.A. 103, 18609-18614.
29. Citron, B. A., Suo, Z., SantaCruz, K., Davies, P. J., Qin, F., and Festoff, B. W. (2002) Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration, Neurochem. Int. 40, 69-78.
30. Festoff, B. W., SantaCruz, K., Arnold, P. M., Sebastian, C. T., Davies, P. J., and Citron, B. A. (2002) Injury-induced "switch" from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord, J. Neurochem. 81, 708-718.
31. Fraij, B. M., Birckbichler, P. J., Patterson, M. K. Jr., Lee, K. N., and Gonzales, R. A. (1992) A retinoic acid-inducible mRNA from human erythroleukemia cells encodes a novel tissue transglutaminase homologue, J. Biol. Chem. 267, 22616-22623.
32. Im, M. J., Russell, M. A., and Feng, J. F. (1997) Transglutaminase II: a new class of GTP-binding protein with new biological functions, Cell Signal. 9, 477-482.
33. Liu, S., Cerione, R. A., and Clardy, J. C. (2002) Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity, Proc. Natl. Acad. Sci. 99, 2743-2747.
34. Begg, G. E., Holman, S. R., Stokes, P. H., Matthews, J. M., Graham, R. M., and Iismaa, S. E. (2006) Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity, J. Biol. Chem. 281, 12603-12609.
35. Day, N., and Keillor, J. W. (1999) A continuous spectrophotometric linked enzyme assay for transglutaminase activity, Anal. Biochem. 274, 141-144.
36. Fraij, B. M. (1996) GTP hydrolysis by human tissue transglutaminase homologue, Biochem. Biophys. Res. Commun. 218, 45-49.
37. Lee, K. N., Birckbichler, P. J., and Patterson, M. K. (1989) GTP hydrolysis by guinea pig liver transglutaminase, Biochem. Biophys. Res. Commun. 162, 1370-1375.
38. Singh, U. S., Erickson, J. W., and Cerione, R. A. (1995) Identification and biochemical characterization of an 80 kilodalton GTP-binding/ transglutaminase from rabbit liver nuclei, Biochemistry 34, 15863-15871.
39. Iismma, S. E., Wu, M.-J., Nanda, N., Church, W. B., and Graham, R. M. (2000) GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket, J. Biol. Chem. 275, 18259-18265.
40. Lai, T.-S., Liu, Y., Li, W., and Greenberg, C. S. (2007) Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells, FASEB J. online communication.
41. Achyuthan, K. E., and Greenberg, C. S. (1987) Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity, J. Biol. Chem. 262, 1901-1906.
42. Lai, T. S., Slaughter, T. F., Peoples, K. A., Hettasch, J. M., and Greenberg, C. S. (1998) Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP, J. Biol. Chem. 273, 1776-1781.
43. Antonyak, M. A., McNeill, C. J., Wakshlag, J. J., Boehm, J. E., and Cerione, R. A. (2003) Activation of the Ras-ERK pathway inhibits retinoic acid-induced stimulation of tissue transglutaminase expression in NIH3T3 cells, J. Biol. Chem. 278, 15859-15866.
44. Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Constantini, P., Loeffler, M., Larochette, N., Goodlett, D. R., Aebersold, R., Siderovski, D. P., Penninger, J. M., and Kroemer, G. (1999) Molecular characterization of mitochondrial apoptosis-induced factor, Nature 397, 441-446.
45. Milakovic, T., Tucholski, J., McCoy, E., and Johnson, G. V. (2004) Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death, J. Biol. Chem. 279, 8715-8722.
46. Feng, J.-F., Rhee, S. G., and Im, M.-J. (1996) Evidence that phospholipase deltal is the effector in the Gh (transglutaminase II)-mediated signaling, J. Biol. Chem. 271, 16451-16454.
47. Nakaoka, H., Perez, D. M., Baek, K. J., Das, T., Husain, A. M., Misono, K., Im, M. J., and Graham, R. M. (1994) Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function, Science 264, 1593-1596.
48. Chen, S., Lin, F., Iismaa, S., Lee, K. N., Birckbichler, P. J., and Graham, R. M. (1996) Alpha1-adrenergic receptor signaling via Gh is subtype specific and independent of its transglutaminase activity, J. Biol. Chem. 271, 32385-32391.
49. Vezza, R., Habib, A., and FitzGerald, G. A. (1999) Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein, Gh, J. Biol. Chem. 274, 12774-12779.
50. Zhang, Z., Vezza, R., Plappert, T., McNamara, P., Lawson, J. A., Austin, S., Pratico, D., Sutton, M. S., and FitzGerald, G. A. (2003) COX-2-dependent cardiac failure in Gh/tTG transgenic mice, Circ. Res. 92, 1153-1161.
51. Park, E. S., Won, J. H., Han, K. J., Suh, P. G., Ryu, S. H., Lee, H. S., Yun, H. Y., Kwon, N. S., and Baek, K. J. (1998) Phospholipase C-delta1 and oxytocin receptor signalling: evidence of its role as an effector, Biochem. J. 331, 283-289.
52. Nanda, N., Iismaa, S. E., Owens, W. A., Husain, A., Mackay, F., and Graham, R. M. (2001) Targeted inactivation of Gh/tissue transglutaminase II, J. Biol. Chem. 276, 20673-20678.
53. De Laurenzi, V., and Melino, G. (2001) Gene disruption of tissue transglutaminase, Mol. Cell Biol. 21, 148-155.
54. Shinzawa, K., and Tsujimoto, Y. (2003) PLA2 activity is required for nuclear shrinkage in caspase-independent cell death, J. Cell Biol. 163, 1219-1230.
55. Kroemer, G., and Martin, S. J. (2005) Caspase-independent cell death, Nat. Med. 11, 725-730.
56. Yuan, L., Choi, K., Khosla, C., Zheng, X., Higashikubo, R., Chicoine, M. R., and Rich, K. M. (2005) Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas, Mol. Cancer Ther. 4, 1293-1302.
57. Choi, K., Siegel, M., Piper, J. L., Yuan, L., Cho, E., Strnad, P., Omary, B., Rich, K. M., and Khosla, C. (2005) Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2, Chem. Biol. 12, 469-475.
58. Keillor, J. W. (2005), Chem. Biol. 12, 469-475.
59. Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673-4680.